Showing 2331-2340 of 8627 results for "".
Try New Things
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/try-new-things/19690/For the field of aesthetics to move forward, innovation is essential. Brian Biesman, MD discusses a responsible approach to trying new things in the clinical setting and stresses the need for caution at times.Microneedling v. Fractional Resurfacing: When and Why
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/microneedling-v-fractional-resurfacing-when-and-why/19688/Data suggest that microneedling can be as effective as nonablative fractional resurfacing for improvement of acne scars. So when is each indicated? Deirdre Hooper, MD discusses a role for combination approaches.Elastin - The underappreciated skin fundamental
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/elastin-the-underappreciated-skin-fundamental/19672/Join Macrene Alexiades, MD, PhD, FAAD as she discusses elastin and its role as a critical, yet often underappreciated, skin fundamental. In this webinar, she explains why lack of elastin is the root cause of skin laxity and what happens when there is a cessation of elastin synthesis. Dr. Alexiades rWhy your dermatology practice isn’t ranking well on Google
https://practicaldermatology.com/topics/practice-management/why-your-dermatology-practice-isnt-ranking-well-on-google/19647/If your dermatology website isn’t ranking well on Google, there are hundreds of possible reasons why. However, in many cases the answer is quite simple. This Ekwa Marketing video explains some of the most common mistakes, and what to do about them.DermWireTV: AbbVie to Acquire Allergan, Duobrii Launches, SDPA at 25
https://practicaldermatology.com/topics/psoriasis/dermwiretv-abbvie-to-acquire-allergan-duobrii-launches-sdpa-at-25/19629/In a deal with an equity value of approximately $63 billion, AbbVie has agreed to acquire Allergan. The new company is positioned for new growth platforms and a diversified revenue base; the deal will be immediately accretive to earnings per share, AbbVie says. The Society of Dermatology Physician ABTL, Sciton Updates; Sun Gets PsO Real
https://practicaldermatology.com/topics/psoriasis/dermwire-tv-btl-sciton-updates-sun-gets-pso-real/19601/BTL rolls out a small Emsculpt applicator to treat arms, thighs and calves at ASLMS. Sciton introduces JOULE X. In conjunction with Sun Pharma, the Association for Applied and Therapeutic Humor is offering strategies to help psoriasis patients navigate emotional challenges and uncomfortable psoriasiPrivate Equity in Dermatology: An Inside View
https://practicaldermatology.com/topics/practice-management/private-equity-in-dermatology-an-inside-view/18219/Private equity firms are turning their attention to the dermatology specialty. Why? How has the market changed and what may be on the horizon? An investment banker with knowledge of the field weighs in with an overview from him perspective.Sunscreen Ratings, Long Live Skin Launches, SCALE Highlights
https://practicaldermatology.com/topics/skin-cancer-photoprotection/dermwiretv-sunscreen-ratings-long-live-skin-launches-scale-highlights/18471/Consumer Reports says that one-third of sunscreens tested in its latest evaluation provided less than half of the SPF protection touted on the label. For its part, the American Academy of Dermatology is reminding patients that sunscreen ingredients are safe. The Environmental Working Group continuesYelp Reviews
https://practicaldermatology.com/topics/practice-management/yelp-reviews/18517/A proper response to negative Yelp reviews could be helpful to your practice. It starts with claiming your free business page. This Ekwa.com educational video explains the steps to take.All in One
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/all-in-one/18726/The Sciton Joule platform offers multiple treatment options to address multiple indications in a single, scalable system, making it a top laser platform pick for 2017, says Dr. Cohen during Cosmetic Surgery Forum.